Form 10-Q · Quarterly report
DaVita 10-Q, filed Aug 4, 2026
- Filed
- CIK
- 0000927066
- Accession no.
- 0000927066-26-000108
Summary
DaVita filed its quarterly report with the SEC, disclosing its management discussion and analysis of financial condition and results of operations. The filing describes its U.S. dialysis business, U.S. integrated kidney care and ancillary services, and international operations, and cites risks including the 2025 cybersecurity incident, federal reimbursement and policy changes, tariffs and supply costs, commercial payor mix, and competition from new entrants and innovative treatments.
Key points
- DaVita operates a U.S. dialysis business alongside U.S. integrated kidney care and ancillary services and international operations.
- The company cited the cybersecurity incident it experienced in 2025 as a factor affecting its business.
- DaVita flagged potential impacts from federal funding and reimbursement rates for Medicare, Medicare Advantage and Medicaid.
- The filing cited evolving trade policies and tariffs, supplier reliance, and new or potential entrants in the dialysis and pre-dialysis marketplace as risks.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Forward-looking statements This Quarterly Report on Form 10-Q, including this Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains statements that are forward-looking statements within the meaning of the federal securities laws and as such are intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.